TP53 and breast carcinoma: A respective analysis of the TCGA invasive breast cancer data set further revealed that inactivation of the p53 pathway is extremely common,affecting >85% of all breast cancer cases regardless of intrinsic subtypes (and TP53 mutation status)12.